UPDATE: Imperva, Inc. (IMPV) Tops Q3 EPS by 3c; Guides Q4, FY12
(Updated - November 2, 2012 8:09 AM EDT)
(GAAP/non-GAAP correction) Imperva, Inc. (NYSE: IMPV) reported Q3 non-GAAP EPS of ($0.00), $0.03 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $26.3 million versus the consensus estimate of $24.88 million.
Imperva, Inc. sees Q4 2012 EPS of $0.01-0.02, versus the consensus of $0.04. Imperva, Inc. sees Q4 2012 revenue of $29.5-30.0 million, versus the consensus of $29.63 million.
Imperva, Inc. sees FY2012 EPS of $0.11-0.12, versus the consensus of $-0.12. Imperva, Inc. sees FY2012 revenue of $102-102.5 million, versus the consensus of $100.49 million.
(GAAP/non-GAAP correction) Imperva, Inc. (NYSE: IMPV) reported Q3 non-GAAP EPS of ($0.00), $0.03 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $26.3 million versus the consensus estimate of $24.88 million.
Imperva, Inc. sees Q4 2012 EPS of $0.01-0.02, versus the consensus of $0.04. Imperva, Inc. sees Q4 2012 revenue of $29.5-30.0 million, versus the consensus of $29.63 million.
Imperva, Inc. sees FY2012 EPS of $0.11-0.12, versus the consensus of $-0.12. Imperva, Inc. sees FY2012 revenue of $102-102.5 million, versus the consensus of $100.49 million.
For earnings history and earnings-related data on Imperva, Inc. (IMPV) click here.